Susanne Adam

List of publications:

BibTeX-Download

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Department of Medicine 3 – Rheumatology and Immunology

Publications

(8)

The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis (2022) Royzman D, Andreev D, Stich L, Peckert K, Wild A, Zinser E, Mühl-Zürbes P, et al. Journal article Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis (2020) Taubmann J, Krishnacoumar B, Böhm C, Faas M, Müller D, Adam S, Stoll C, et al. Journal article HIGH REMISSION RATES IN RA - REAL LIFE DATA FROM BARITICINIB (2020) Bayat S, Tascilar K, Kaufmann V, Kleyer A, Simon D, Knitza J, Hartmann F, et al. Conference contribution JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function (2020) Adam S, Simon N, Steffen U, Andes FT, Scholtysek C, Müller D, Weidner D, et al. Journal article The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption (2020) Andes FT, Adam S, Hahn M, Aust O, Frey S, Grüneboom A, Nitschke L, et al. Journal article Structural insights into heme binding to IL-36α proinflammatory cytokine (2019) Wißbrock A, Goradia NB, Kumar A, Paul George AA, Kühl T, Bellstedt P, Ramachandran R, et al. Journal article JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO (2019) Adam S, Simon N, Steffen U, Harre N, Andes F, Mueller D, Culemann S, et al. Conference contribution Full Length Interleukin 33 Aggravates Radiation-Induced Skin Reaction (2017) Kurow O, Frey B, Schuster L, Schmitt V, Adam S, Hahn M, Gilchrist D, et al. Journal article